Biliary Stents Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Biliary Stents Market size was valued at USD 162.1 million in 2026 and is anticipated to grow at a 4.75% CAGR from 2027 to 2036, reaching USD 257.82 million by 2036. The industry revenue for 2027 is calculated at USD 168.58 million.

• Base Year Value (2026): USD 162.1 million
• CAGR (2027-2036): 4.75%
• Forecast Year Value (2036): USD 257.82 million
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Biliary Stents Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America leads due to established endoscopy infrastructure, broad access to minimally invasive biliary procedures, specialist availability, and consistently high procedural volumes across hospitals and gastroenterology centers.
  • Asia Pacific is projected to grow at a 5.88% CAGR, supported by expanding hospital capabilities, greater access to endoscopic interventions, and increasing uptake of gastrointestinal and hepatobiliary care.

• Segment Momentum:

  • Metal biliary stents held a 64.98% market share in 2026 due to their longer patency, durability, and reduced replacement frequency, helping providers improve procedural efficiency and manage biliary obstruction with fewer repeat interventions.
  • Ambulatory Surgical Centers are growing fastest as more suitable biliary procedures move to outpatient settings that offer streamlined workflows, shorter stays, and efficient treatment pathways for minimally invasive interventions.

• Market Expansion Drivers:

  • Rising prevalence of biliary disorders and chronic liver diseases increasing interventional treatment demand.
  • Expanding adoption of endoscopic luminal stenting for malignant and non-neoplastic biliary obstructions.
  • Advancements in drug-eluting and self-expanding stent technologies improving procedural outcomes and durability.

• Leading Market Participants:

  Key players in the biliary stents market include Boston Scientific Corporation (United States), Cook Medical LLC (United States), Olympus Corporation (Japan), Becton, Dickinson and Company (United States), Medtronic plc (Ireland), Teleflex Incorporated (United States), ConMed Corporation (United States), Taewoong Medical Co., Ltd. (South Korea), Merit Medical Systems, Inc. (United States), Micro-Tech (Nanjing) Co., Ltd. (China).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 162.1 million
  • 2027 Estimated Market Size: USD 168.58 million.
  • Projected Market Size: USD 257.82 million by 2036
  • Growth Forecasts: 4.75% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Metal (Type) | Hospitals (End-use) | Gallstones (Application)
  • Emerging Opportunity Segment: Polymer (Type) | Ambulatory Surgical Centers (End-use) | Benign Biliary Structures (Application)

Market Growth Drivers and Industry Trends

Rising prevalence of biliary disorders and chronic liver diseases increasing interventional treatment demand

The growing burden of biliary disorders and chronic liver diseases is increasing the number of patients requiring interventions to restore or maintain bile flow, supporting biliary stents market growth. Biliary obstruction can lead to significant complications when normal drainage is impaired, creating demand for minimally invasive procedures that can relieve blockages and maintain ductal patency. As interventional approaches become an important component of managing obstructive biliary conditions, stenting solutions remain relevant across procedures addressing different underlying causes of biliary narrowing or blockage.

Expanding adoption of endoscopic luminal stenting for malignant and non-neoplastic biliary obstructions

Increasing use of endoscopic luminal stenting is strengthening demand for biliary stent technologies across both malignant and non-neoplastic obstructions, which will drive the biliary stents market growth. Endoscopic placement provides a minimally invasive approach for restoring biliary drainage while addressing obstructions associated with different clinical conditions. The ability to deploy stents within the biliary tract supports their use in procedures where maintaining an open lumen is important for managing obstruction and facilitating bile flow.

Advancements in drug-eluting and self-expanding stent technologies improving procedural outcomes and durability

Technological improvements in drug-eluting and self-expanding stents are enhancing the functionality of biliary intervention products, thereby boosting the biliary stents market demand. Drug-eluting designs can support localized delivery of therapeutic agents, while self-expanding technologies provide controlled expansion within the biliary tract to maintain lumen patency. Improvements in stent design and material performance can also contribute to greater procedural reliability and durability, supporting the use of advanced stenting solutions in complex biliary interventions.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of biliary disorders and chronic liver diseases increasing interventional treatment demand	2.00%	Moderate	North America, Europe	High	Near Term
Expanding adoption of endoscopic luminal stenting for malignant and non-neoplastic biliary obstructions	1.80%	High	North America, Asia Pacific	High	Mid Term
Advancements in drug-eluting and self-expanding stent technologies improving procedural outcomes and durability	1.30%	Moderate	Europe, Asia Pacific	Emerging	Long Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

In the biliary stents market, North America held the largest share in 2026, benefiting from advanced healthcare infrastructure, established endoscopic treatment capabilities, and strong demand for minimally invasive management of biliary disorders. The region's mature hospital and specialty care network supports the use of biliary stents across diagnostic and therapeutic procedures, while continued advances in interventional techniques are encouraging the adoption of improved stent technologies. Growing emphasis on minimally invasive treatment, combined with greater access to specialized gastrointestinal care, is supporting procedure volumes and reinforcing demand. Ongoing improvements in clinical practice and healthcare delivery further contribute to North America's established position in the market.

Asia Pacific represents the fastest-growing region for the biliary stents market, supported by expanding healthcare infrastructure, improving access to advanced endoscopic procedures, and rising demand for minimally invasive interventions. Increasing investment in hospitals and specialty treatment facilities is strengthening the availability of gastrointestinal and hepatobiliary care across developing healthcare systems. Greater awareness of treatment options and the gradual expansion of specialist expertise are also encouraging wider adoption of biliary stenting procedures. At the same time, technological improvements in stent design and procedural techniques are supporting more effective treatment approaches, while the region's expanding patient population and improving healthcare accessibility provide a favorable foundation for continued market development.

Key Country Insights

United States

Minimally Invasive Procedures

The U.S. biliary stents market benefits from widespread adoption of minimally invasive endoscopic procedures for managing biliary disorders. Healthcare providers increasingly utilize advanced stent technologies that improve procedural efficiency and patient outcomes.

Japan

Precision Gastroenterology Care

Japan emphasizes high-quality biliary stents that support complex gastrointestinal procedures and reliable long-term performance. Healthcare institutions continue adopting refined stent designs suited to advanced endoscopic treatment practices.

South Korea

Advanced Endoscopy Adoption

South Korea is expanding the use of biliary stents as hospitals invest in sophisticated endoscopic capabilities and minimally invasive care. Demand is supported by increasing availability of innovative stent technologies for complex biliary interventions.

Germany

Endoscopic Innovation Focus

Germany continues adopting advanced biliary stents through strong utilization of endoscopic interventions in specialized healthcare facilities. Clinical preference is shifting toward devices that improve placement accuracy and reduce procedure-related complications.

France

Clinical Device Refinement

France prioritizes biliary stents that improve treatment efficiency and procedural safety within gastroenterology services. Healthcare providers continue evaluating advanced materials and designs that support effective biliary drainage procedures.

Italy

Specialized Gastrointestinal Care

Italy is strengthening biliary stent utilization through expanding access to specialized gastrointestinal and endoscopic treatment centers. Hospitals continue adopting modern stent solutions that enhance procedural consistency and patient management.

Segment Leadership and Growth Trends

 

Type Segment Analysis: Metal (Largest Segment) vs Polymer (Fastest-Growing Segment)

The metal segment held the largest share of the biliary stents market at 64.98% in 2026, supported by the durability, radial strength, and sustained ductal patency offered by metal stents in the management of biliary obstruction. Their ability to maintain an open passage in challenging clinical situations makes them valuable in procedures involving malignant and complex biliary strictures. Growing demand for minimally invasive management of biliary disorders and continued advances in stent design are supporting adoption. The established clinical use of metal stents and their suitability for longer-term drainage further reinforce their leading position.

Polymer stents are gaining momentum as physicians seek flexible and clinically versatile options for biliary drainage across a range of therapeutic situations. Their ease of placement and removal, combined with suitability for temporary drainage and repeated interventions, makes polymer designs valuable in selected patient populations. Continued refinement of stent materials and delivery systems is improving procedural convenience and expanding their clinical applicability. Increasing preference for less invasive interventions and individualized biliary management is supporting faster adoption of polymer stents.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals led the biliary stents market in 2026, reflecting their role as major centers for complex gastroenterological procedures, advanced imaging, emergency care, and multidisciplinary management of biliary disorders. Hospitals possess the specialized infrastructure and trained personnel required for endoscopic and interventional procedures, particularly for patients with complicated obstructions or underlying diseases. The availability of comprehensive diagnostic and postoperative support further sustains demand for biliary stent procedures in hospital settings. Increasing diagnosis and treatment of biliary conditions is therefore reinforcing the segment's established position.

Ambulatory surgical centers are expanding more rapidly as healthcare systems increasingly shift suitable minimally invasive procedures toward outpatient settings. These facilities can offer procedural care with greater operational efficiency while supporting shorter patient stays and potentially lower treatment burdens. Improvements in endoscopic techniques, anesthesia practices, and patient selection are making biliary interventions increasingly suitable for ambulatory environments. The broader movement toward cost-conscious, convenient procedural care is expected to encourage greater adoption of biliary stent procedures in ambulatory surgical centers.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Type	Metal, Polymer, Plastic	Metal	Polymer
End-use	Hospitals, Ambulatory Surgical Centers, Others	Hospitals	Ambulatory Surgical Centers
Application	Bilio-pancreatic Leakages, Pancreatic Cancer, Benign Biliary Structures, Gallstones, Others	Gallstones	Benign Biliary Structures

Competitive Landscape and Market Positioning

Top players in the biliary stents market:

1. Boston Scientific Corporation (United States)

2. Cook Medical LLC (United States)

3. Olympus Corporation (Japan)

4. Becton Dickinson and Company (United States)

5. Medtronic plc (Ireland)

6. Teleflex Incorporated (United States)

7. ConMed Corporation (United States)

8. Taewoong Medical Co. Ltd. (South Korea)

9. Merit Medical Systems Inc. (United States)

10. Micro-Tech (Nanjing) Co. Ltd. (China)

The biliary stents market is witnessing advancements focused on improving procedural efficiency, patient recovery, and long-term stent performance. Manufacturers are introducing enhanced stent designs with improved flexibility, biocompatibility, and anti-migration features to address complex clinical requirements. Growing preference for minimally invasive treatments is also supporting innovation in the biliary stents market.

Industry Development/News

Company Name	Date	Key Development
CGBIO	Jul-24	CGBIO received product approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its ARISTENT biliary stents. This milestone facilitates the company’s commercial entry into the Japanese market and supports its broader strategy to accelerate global expansion through regulatory-backed product launches.
Olympus Corporation	Dec-25	Olympus Corporation, W. L. Gore & Associates, and ConMed Corporation announced a transition in commercial support for the GORE VIABIL Biliary Endoprosthesis. Olympus assumed distribution duties in the U.S., integrating the stent into its established endotherapy sales network to strengthen its competitive position in the fully covered metal biliary stent segment.
TaeWoong Medical	May-26	TaeWoong Medical USA received U.S. FDA 510(k) clearance for the Niti-S SPAXUS Stent. This fully covered, self-expanding metallic stent is designed for EUS-guided procedures, enabling a commercial launch in the U.S. that enhances the company’s portfolio for minimally invasive biliary drainage and therapeutic endoscopy.